|
|
||||||||
From the Departments of Neurosciences (Drs. Merdes, Hansen, Galasko, Hofstetter, Ho, Thal, and Corey-Bloom), Pathology (Dr. Hansen), and Psychiatry (Dr. Jeste), University of California, San Diego; and Neurology Service (Drs. Galasko, Thal, and Corey-Bloom), San Diego Veterans Affairs Medical Center, La Jolla, CA.
Address correspondence and reprint requests to Dr. Jody Corey-Bloom, Professor of Neurosciences, UCSD School of Medicine, VA Neurology Service (9127), 3350 La Jolla Village Drive, San Diego, CA 92161; e-mail: jcoreybl{at}vapop.ucsd.edu
Objective: To determine whether AD neurofibrillary pathology influences clinical diagnostic accuracy in dementia with Lewy bodies (DLB).
Background: Pathologic diagnosis of DLB mandates Lewy bodies but also allows for AD pathology in the form of plaques and tangles. Because clinical diagnostic accuracy of DLB remains low, the authors questioned whether the severity of AD pathology in the form of tangles might affect the clinicians ability to correctly diagnose DLB in life. Design/Methods: Ninety-eight subjects with autopsy-proven DLB who had been evaluated annually at the University of California San Diego AD Research Center were identified. The clinical diagnosis used was the last diagnosis before death. Pathologic diagnosis of DLB was made according to Consensus guidelines, and Braak staging was used to assess the degree of neurofibrillary AD pathology. The clinical characteristics of subjects with DLB with low vs high Braak stages were compared and the clinical diagnostic accuracy for subjects stratified according to Braak stage was determined.
Results: Only 27% of the subjects with DLB demonstrated both visual hallucinations and spontaneous extrapyramidal signs (EPS). The low Braak stage (0 to 2, n = 24) subjects had a higher frequency of visual hallucinations (65%) than did subjects with DLB with higher (3 to 6, n = 66) Braak stages (33%, p = 0.008), and showed a slightly greater but not significant degree of EPS. Although clinical diagnostic accuracy for DLB was relatively low (49%), it was higher for subjects with low (75%) compared to high (39%) Braak stages (p = 0.0039).
Conclusions: The degree of concomitant AD tangle pathology has an important influence on the clinical characteristics and, therefore, the clinical diagnostic accuracy of DLB.
This article has been cited by other articles:
![]() |
G. J. Revuelta, A. Rosso, and C. F. Lippa Neuritic Pathology as a Correlate of Synaptic Loss in Dementia With Lewy Bodies American Journal of Alzheimer's Disease and Other Dementias, March 1, 2008; 23(1): 97 - 102. [Abstract] [PDF] |
||||
![]() |
L. Bonanni, A. Thomas, P. Tiraboschi, B. Perfetti, S. Varanese, and M. Onofrj EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up Brain, March 1, 2008; 131(3): 690 - 705. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Jellinger IN DEMENTIA WITH LEWY BODIES, BRAAK STAGE DETERMINES PHENOTYPE, NOT LEWY BODY DISTRIBUTION Neurology, January 29, 2008; 70(5): 407 - 408. [Full Text] [PDF] |
||||
![]() |
J. A. Levy and G. J. Chelune Cognitive-Behavioral Profiles of Neurodegenerative Dementias: Beyond Alzheimer's Disease J Geriatr Psychiatry Neurol, December 1, 2007; 20(4): 227 - 238. [Abstract] [PDF] |
||||
![]() |
D. Weisman, M. Cho, C. Taylor, A. Adame, L. J. Thal, and L. A. Hansen In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution Neurology, July 24, 2007; 69(4): 356 - 359. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Rowe, S. Ng, U. Ackermann, S. J. Gong, K. Pike, G. Savage, T. F. Cowie, K. L. Dickinson, P. Maruff, D. Darby, et al. Imaging {beta}-amyloid burden in aging and dementia Neurology, May 15, 2007; 68(20): 1718 - 1725. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Whitwell, C. R. Jack Jr, J. E. Parisi, D. S. Knopman, B. F. Boeve, R. C. Petersen, T. J. Ferman, D. W. Dickson, and K. A. Josephs Rates of cerebral atrophy differ in different degenerative pathologies Brain, April 1, 2007; 130(4): 1148 - 1158. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Lippa, J. E. Duda, M. Grossman, H. I. Hurtig, D. Aarsland, B. F. Boeve, D. J. Brooks, D. W. Dickson, B. Dubois, M. Emre, et al. DLB and PDD boundary issues: Diagnosis, treatment, molecular pathology, and biomarkers Neurology, March 13, 2007; 68(11): 812 - 819. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Whitwell, S. D. Weigand, M. M. Shiung, B. F. Boeve, T. J. Ferman, G. E. Smith, D. S. Knopman, R. C. Petersen, E. E. Benarroch, K. A. Josephs, et al. Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease Brain, March 1, 2007; 130(3): 708 - 719. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Williams, C. Xiong, J. C. Morris, and J. E. Galvin Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease Neurology, December 12, 2006; 67(11): 1935 - 1941. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Tsuang, K. Simpson, E. B. Larson, E. Peskind, W. Kukull, J. B. Bowen, W. McCormick, L. Teri, T. Montine, M. L. Thompson, et al. Predicting lewy body pathology in a community-based sample with clinical diagnosis of Alzheimer's disease. J Geriatr Psychiatry Neurol, December 1, 2006; 19(4): 195 - 201. [Abstract] [PDF] |
||||
![]() |
S. Papapetropoulos, A. Lieberman, J. Gonzalez, C. Singer, D. Z. Laufer, and D. C. Mash Family history of dementia: dementia with lewy bodies and dementia in Parkinson's disease. J Neuropsychiatry Clin Neurosci, December 1, 2006; 18(1): 113 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Lippa An Individualized Approach to Treatment for Alzheimer's Disease, Pick's Disease, and Other Dementias. American Journal of Alzheimer's Disease and Other Dementias, October 1, 2006; 21(5): 354 - 359. [Abstract] [PDF] |
||||
![]() |
K. Stavitsky, A. M. Brickman, N. Scarmeas, R. L. Torgan, M.-X. Tang, M. Albert, J. Brandt, D. Blacker, and Y. Stern The progression of cognition, psychiatric symptoms, and functional abilities in dementia with lewy bodies and Alzheimer disease. Arch Neurol, October 1, 2006; 63(10): 1450 - 1456. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bibl, B. Mollenhauer, H. Esselmann, P. Lewczuk, H.-W. Klafki, K. Sparbier, A. Smirnov, L. Cepek, C. Trenkwalder, E. Ruther, et al. CSF amyloid-{beta}-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia Brain, May 1, 2006; 129(5): 1177 - 1187. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Leverenz, M. A. Fishel, E. R. Peskind, T. J. Montine, D. Nochlin, E. Steinbart, M. A. Raskind, G. D. Schellenberg, T. D. Bird, and D. Tsuang Lewy Body Pathology in Familial Alzheimer Disease: Evidence for Disease- and Mutation-Specific Pathologic Phenotype. Arch Neurol, March 1, 2006; 63(3): 370 - 376. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Tiraboschi, D. P. Salmon, L. A. Hansen, R. C. Hofstetter, L. J. Thal, and J. Corey-Bloom What best differentiates Lewy body from Alzheimer's disease in early-stage dementia? Brain, March 1, 2006; 129(3): 729 - 735. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. G. McKeith, D. W. Dickson, J. Lowe, M. Emre, J. T. O'Brien, H. Feldman, J. Cummings, J. E. Duda, C. Lippa, E. K. Perry, et al. Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium Neurology, December 27, 2005; 65(12): 1863 - 1872. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Johnson, J. C. Morris, and J. E. Galvin Verbal and visuospatial deficits in dementia with Lewy bodies Neurology, October 25, 2005; 65(8): 1232 - 1238. [Abstract] [Full Text] [PDF] |
||||
![]() |
J M Olichney, C Murphy, C R Hofstetter, K Foster, L A Hansen, L J Thal, and R Katzman Anosmia is very common in the Lewy body variant of Alzheimer's disease J. Neurol. Neurosurg. Psychiatry, October 1, 2005; 76(10): 1342 - 1347. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Lippa, C. F. Lippa, and H. Mori {alpha}-Synuclein aggregation in pathological aging and Alzheimer's disease: The impact of {beta}-amyloid plaque level American Journal of Alzheimer's Disease and Other Dementias, September 1, 2005; 20(5): 315 - 318. [Abstract] [PDF] |
||||
![]() |
M. L. Kraybill, E. B. Larson, D. W. Tsuang, L. Teri, W. C. McCormick, J. D. Bowen, W. A. Kukull, J. B. Leverenz, and M. M. Cherrier Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both Neurology, June 28, 2005; 64(12): 2069 - 2073. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Z. Press Parkinson's Disease Dementia -- A First Step? N. Engl. J. Med., December 9, 2004; 351(24): 2547 - 2549. [Full Text] [PDF] |
||||
![]() |
D. Aarsland, C. G. Ballard, and G. Halliday Are Parkinson's Disease with dementia and Dementia with lewy Bodies the Same Entity? J Geriatr Psychiatry Neurol, September 1, 2004; 17(3): 137 - 145. [Abstract] [PDF] |
||||
![]() |
D J Burn Cortical Lewy body disease J. Neurol. Neurosurg. Psychiatry, February 1, 2004; 75(2): 175 - 178. [Full Text] [PDF] |
||||
![]() |
K. A. Jellinger, J. Corey-Bloom, A. R. Merdes, and L. A. Hansen Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies Neurology, January 13, 2004; 62(1): 160 - 160. [Full Text] [PDF] |
||||
![]() |
C. F. Lippa and I. McKeith Dementia with Lewy bodies: Improving diagnostic criteria Neurology, May 27, 2003; 60(10): 1571 - 1573. [Full Text] [PDF] |
||||
Read all Correspondence
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |